“They don’t understand or like the idea that they are permanent. For patients who have angioplasty, their vessels regrow in one to five years, but if you have a metallic stent, that’s not a possibility. Now we are able to restore that possibility, we have a stent that degrades.”
— Richard Rapoza, PhD, VP of research and development for the bioabsorbable stent program at Abbott Laboratories discussing the results of his company’s ABSORB trial for a bioabsorbable stent, the first degradable stent to be tested on humans, “Abbott’s bioabsorbable stent trial shows promise out to one-year,” pp. 1, 6.